DGAP-News

MeVis Medical Solutions AG: MeVis gains first industrial customer for lung screening software

DGAP-News: MeVis Medical Solutions AG / Key word(s): Product Launch
MeVis Medical Solutions AG: MeVis gains first industrial customer for
lung screening software

14.08.2014 / 17:45

---------------------------------------------------------------------

Industrial customer uses MeVis' software for early entry into growth market
of lung cancer screening

- Planned integration of MeVis' lung screening software for efficient
interpretation of CT chest images in comprehensive lung screening
solution of industrial customer

- Product release at RSNA in November 2014, the world's most important
annual meeting of American radiologists

- Improved workflow, high diagnostic quality particularly and support of
patient management systems particularly with higher caseloads such as
in future national lung screening programs

- Market potential especially in the US

- First revenues expected in the first quarter 2015

Bremen, August 14, 2014 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4],
a leading provider of medical imaging software, announces, that they signed
a contract with an important industrial customer for use of the MeVis'
software for improving the early detection of lung cancer within lung
screenings.

Besides prostate, colon and breast cancer, lung cancer is today among the
four most common cancers. But since it is noticable relatively late by
symptoms and discomfort, an early diagnosis is of essential importance for
treatment and the prognosis of patients. Way back there have already been
discussions about the possibilities of early detection of lung cancer. And,
at least for the U.S., the introduction of appropriate screening programs
based on CT images are within reach since mid 2013. In national studies
(Early Lung Cancer Action Project - ELCAP and National Lung Screening Trial
- NLST) in the United States it has been verified that CT lung screening is
far superior in detection of lung cancer at an early stage compared to
normal radiography. And thus the responsible Expert Committee (USPSTF) has
issued a recommendation for a lung screening in December 2013. Accordingly,
a strong increase in lung CT images, which need to be diagnosed, is
expected. MeVis assumes that, as a result, there will be an increased
demand for solutions that simplify, shorten and improve the quality of this
this procedure. An introduction in Europe is also discussed.

MeVis' software, the world's first dedicated software for the efficient
diagnosis of images from CT lung screening, combined with a patient
management software from the industrial customer and a training solution
based on the MeVis Online Academy will be launched initially in the USA.